- All regions
- Asia
Hong Kong
India
Japan
Korea, Republic of
Singapore
Taiwan- Australasia
Australia
New Zealand- Europe
Austria
Belgium
Bosnia Herzegovina
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Macedonia
Netherlands
Norway
Poland
Portugal
Romania
Serbia Montenegro
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom- North America
Canada
United States
Top Healthcare stocks in United States
Manufacturers, developers and marketers of pharmaceuticals, medical equipment and supplies, as well as advanced therapeutic treatments and devices, and providers of healthcare facilities and medical research and development.
| Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
|---|---|---|---|
 KYMRKymera Therapeutics | $10.94bn | n/a | n/a |
| BMRNBioMarin Pharmaceutical | $10.87bn | 21.53 | n/a |
| PODDInsulet | $10.83bn | 25.45 | n/a |
| RGENRepligen | $10.77bn | 266.03 | n/a |
| ENSGEnsign group | $10.64bn | 26.61 | 0.14% |
| QGENQIAGEN | $10.50bn | 22.5 | 0.49% |
| AVTRAvantor | $10.26bn | 26.65 | n/a |
| BIO BBio-Rad Laboratories | $9.92bn | 8.05 | n/a |
| BIOBio-Rad Laboratories | $9.92bn | 7.82 | n/a |
| NUVLNuvalent, | $9.80bn | n/a | n/a |
| RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
| HSICHenry Schein | $9.43bn | 19.66 | n/a |
| PCVXVaxcyte | $9.42bn | n/a | n/a |
| MASIMasimo | $9.37bn | 43.74 | n/a |
| MDGLMadrigal Pharmaceuticals | $9.29bn | n/a | n/a |
| SYRESpyre Therapeutics | $9.17bn | n/a | n/a |
| VRNAVerona Pharma | $9.09bn | n/a | n/a |
| CRNXCrinetics Pharmaceuticals | $9.00bn | n/a | n/a |
| KRYSKrystal Biotech | $8.90bn | 40.79 | n/a |
| TGTXTG Therapeutics | $8.87bn | 20.7 | n/a |